Enlivex Therapeutics Ltd. (ENLV) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Enlivex Therapeutics Ltd.

    NASDAQ: ENLV · Real-Time Price · USD
    1.03
    0.00 (0.00%)
    At close: Sep 26, 2025, 3:56 PM
    1.02
    -0.97%
    Pre-market: Sep 29, 2025, 05:13 AM EDT

    Enlivex Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.6 -1.73 -2.33 -7.72
    PEG Ratio
    		 0.03 0.05 -0.01 0.16
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.02 1.67 1.28 1.31
    P/FCF Ratio
    		 -1.83 -2.11 -2.26 -5.82
    P/OCF Ratio
    		 -1.85 -2.13 -3.03 -6.36
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.03 0.09 0.01
    Quick Ratio
    		 6.84 5.57 7.74 20.91
    Current Ratio
    		 6.84 5.57 7.92 18.32
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -1.2K -2.1K -4.9 -58.8
    Return on Equity
    		 -0.64 -0.97 -0.55 -0.17
    Return on Assets
    		 -0.54 -0.79 -0.46 -0.15
    Return on Invested Capital
    		 -0.64 -0.94 -0.42 -0.21
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist